Westwood Holdings Group Inc. Makes New Investment in Henry Schein, Inc. $HSIC

Westwood Holdings Group Inc. acquired a new position in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) in the 2nd quarter, Holdings Channel reports. The fund acquired 282,420 shares of the company’s stock, valued at approximately $20,631,000.

A number of other large investors have also recently made changes to their positions in HSIC. Ameriprise Financial Inc. raised its stake in Henry Schein by 3,275.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company’s stock worth $165,594,000 after acquiring an additional 2,199,695 shares during the last quarter. Norges Bank acquired a new position in shares of Henry Schein in the second quarter valued at about $89,476,000. M.D. Sass LLC purchased a new position in shares of Henry Schein in the second quarter worth about $79,201,000. Schroder Investment Management Group lifted its holdings in shares of Henry Schein by 149.3% during the second quarter. Schroder Investment Management Group now owns 1,563,899 shares of the company’s stock worth $114,243,000 after purchasing an additional 936,471 shares during the period. Finally, Bank of America Corp DE lifted its holdings in shares of Henry Schein by 204.2% during the second quarter. Bank of America Corp DE now owns 995,375 shares of the company’s stock worth $72,712,000 after purchasing an additional 668,182 shares during the period. 96.62% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent research reports. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Morgan Stanley raised their target price on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a report on Wednesday, November 5th. Wells Fargo & Company boosted their target price on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 5th. Barclays initiated coverage on Henry Schein in a research report on Monday, December 8th. They set an “overweight” rating and a $86.00 price target on the stock. Finally, Barrington Research set a $79.00 price objective on Henry Schein and gave the company an “outperform” rating in a report on Wednesday, November 5th. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $76.92.

Get Our Latest Report on Henry Schein

Henry Schein Stock Up 0.4%

HSIC opened at $76.55 on Monday. The company has a fifty day moving average of $69.19 and a two-hundred day moving average of $69.53. The stock has a market capitalization of $9.01 billion, a price-to-earnings ratio of 24.22, a PEG ratio of 2.35 and a beta of 0.89. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $82.49. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.79 and a current ratio of 1.40.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.11. Henry Schein had a net margin of 3.02% and a return on equity of 14.76%. The business had revenue of $3.34 billion for the quarter, compared to analyst estimates of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.